Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RIO-North America: Rimonabant in Obesity
NCT00029861Phase 3Completed
- Sponsor
- Sanofi
- Start
- Aug 2001
- Primary completion
- Apr 2004
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of rimonabant in obesity, sponsored by Sanofi. Started Aug 2001; status: completed.
02
Drugs
rimonabant
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00029861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00029861.